Company facts
- Headquarters
- South San Francisco, California
- Most recent report
- 8-K, filed Sep 21, 2026
- Incorporated
- Delaware
- Filings on record
- 33 filings
- On EDGAR
- CIK 2088082
- Fiscal year ends
- December
- Filer status
- Emerging growth company
News 1
Prospectuses and Registrations 4
Ownership 8 of 21
- SCHEDULE 13G Large holder reported a passive stake Sep 28, 2026
- SCHEDULE 13G Large holder reported a passive stake Sep 28, 2026
- SCHEDULE 13D Large holder reported an active stake Sep 25, 2026
- 4 Insider reported a trade Sep 23, 2026
- 4 Insider reported a trade Sep 23, 2026
- 3 Insider reported their initial holding Sep 21, 2026
- 4 Insider reported a trade Sep 21, 2026
- 4 Insider reported a trade Sep 21, 2026
Other 7
- CERT Exchange certified a listing Sep 18, 2026
- 8-A12B Registration of a security for exchange listing Sep 18, 2026
- EFFECT Notice that a registration became effective Sep 17, 2026
- S-1MEF Sep 17, 2026
- DRS/A Draft registration statement, submitted confidentially, amended Aug 10, 2026
- DRS Draft registration statement, submitted confidentially Jun 26, 2026
- D Oct 30, 2025
Everything here comes from Electra Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.